LCH Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH
Langerhans Cell HistiocytosisLCH
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.56 enrolled11 locationsNCT05997602
Recruiting
Not Applicable
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
Acute Coronary SyndromeColchicineUnstable Angina+2 more
Beijing Anzhen Hospital6,574 enrolled1 locationNCT06215989